Use App
Trending
News
Earnings
All
DIA
0.12%
SPY
1.04%
QQQ
2.51%
Trending
AVAX
9.06%
MSTR
3.46%
LWLG
5.39%
RDDT
5.43%
DIA
0.12%
ZVRA
2.30%
CCL
3.21%
TDOC
6.32%
DJT
4.82%
CHIP
0.56%
AVAX
9.06%
MSTR
3.46%
LWLG
5.39%
RDDT
5.43%
DIA
0.12%
ZVRA
2.30%
CCL
3.21%
TDOC
6.32%
DJT
4.82%
CHIP
0.56%
home
Symbol
ASBP
news
Exchange:
NASDAQ
·
Updated 07:48 PM EDT
ASBP
Aspire Biopharma Holdings Inc
$6.58
$0.22
(3.46%)
Today
·
Closed $6.58
$0.30
(4.56%)
After Hours
2
,
2
5
3
2
,
2
5
3
Mkt Cap
$8.24M
Vol
177,144.00
Full Chart
Fundamentals
Mkt Cap
$8.24M
Volume
-
52W High
$1,050.36
52W Low
$3.31
PE Ratio
-0.04
Avg. Volume
745,802.40
EPS (Annual)
-$491.27
P/B
0.28
Rev/Employee
-
Earnings
-
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier?
The company announced the acquisition of Dura Driver Control Systems for $30 million in cash.
Stocktwits
Full Article
Share to Feed
More News
Healthcare Disruption, AI Biologics, and Wall Street Upgrades Ignite a Midday Market Surge
Healthcare innovators are pushing the markets today. $TGNT, $AGL, $ATRA, $ASBP
24-7 Market News
ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity
Aspire Biopharma’s board approved a share repurchase program of up to $5 million, which will be funded from existing cash.
Stocktwits
Full Article
ASBP Bulls Back In Control After 78% Crash: What Changed?
The company closed a $21 million private placement that lifted its shareholders’ equity above Nasdaq’s minimum listing requirement.
Stocktwits
Full Article
LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff?
The declines came amid leadership uncertainty, financing concerns, and downward revisions in price targets from Wall Street analysts.
Stocktwits
Full Article
LCID, ABT, ASBP Stocks Hit 52-Week Lows Today: What’s Driving The Selloff?
LCID and ABT each fell about 6% on Thursday, while ASBP plunged 45%, bucking a broader market rally.
Stocktwits
Full Article
ASBP Stock Soars 32% After Favorable Feedback From FDA For Its Aspirin – Retail Expects Licensing Negotiations Soon
The FDA’s feedback supports a planned new drug application submission in the second half of 2026.
Stocktwits
Full Article
<
...
1
>
Advertisement
|
Remove ads.
Latest ASBP News
View
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier?
Stocktwits
Healthcare Disruption, AI Biologics, and Wall Street Upgrades Ignite a Midday Market Surge
24-7 Market News
ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity
Stocktwits
Loading...
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile